Skip to main content
Top
Published in: Lung 1/2016

Open Access 01-02-2016

Cardiac Sarcoidosis: Is it More Common in Men?

Authors: Magdalena M. Martusewicz-Boros, Piotr W. Boros, Elżbieta Wiatr, Anna Kempisty, Dorota Piotrowska-Kownacka, Kazimierz Roszkowski-Śliż

Published in: Lung | Issue 1/2016

Login to get access

Abstract

Introduction

Sarcoidosis is a systemic granulomatous disease which predominantly affects the lungs, although granulomas can also involve all other organs, including the heart. Cardiac sarcoidosis (CS) may occur at any stage of the disease and may be the cause of sudden cardiac death, even in a previously asymptomatic patient. The aim of this study was to evaluate the incidence of CS in a large group of patients diagnosed or followed up due to sarcoidosis.

Methods

We performed a retrospective analysis of patients at our institution discharged with the final diagnosis “sarcoidosis” (ICD-10: D86) from January 2008 to October 2012. Only those with biopsy (from respiratory tract or lymph nodes) confirmed diagnosis of sarcoidosis were included. We then selected the subset of patients with cardiac involvement due to sarcoidosis confirmed by positive magnetic resonance imaging.

Results

The study covered 1375 consecutive sarcoidosis patients (51 % men), who were hospitalized during 5 years. Multiorgan disease was detected in 160 cases (11.7 %), and cardiac involvement was found in 64 patients (4.7 % of all), 70.3 % of whom were men. Twelve of those with CS were in stage I, 48 in stage II, and four in stage III. The odds ratio for having cardiac involvement in men compared to women was 2.3 (95 % CI 1.36–4.0, p = 0.002).

Conclusions

Cardiac involvement in sarcoidosis was diagnosed in the similar percentage as in previously published data but was significantly more frequently in men.
Literature
1.
go back to reference Statement on sarcoidosis (1999) Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736–755CrossRef Statement on sarcoidosis (1999) Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736–755CrossRef
2.
go back to reference Nelson JE, Kirschner PA, Teirstein AS (1996) Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 13:178–182PubMed Nelson JE, Kirschner PA, Teirstein AS (1996) Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 13:178–182PubMed
3.
go back to reference Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889CrossRefPubMed Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889CrossRefPubMed
4.
go back to reference Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest J 103:253–258CrossRef Sharma OP, Maheshwari A, Thaker K (1993) Myocardial sarcoidosis. Chest J 103:253–258CrossRef
5.
go back to reference Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63:86–108CrossRefPubMed Roberts WC, McAllister HA Jr, Ferrans VJ (1977) Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 63:86–108CrossRefPubMed
6.
go back to reference Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211CrossRefPubMed Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211CrossRefPubMed
7.
go back to reference Mantini N, Williams B Jr, Stewart J et al (2012) Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol 35:410–415CrossRefPubMed Mantini N, Williams B Jr, Stewart J et al (2012) Cardiac sarcoid: a clinician’s review on how to approach the patient with cardiac sarcoid. Clin Cardiol 35:410–415CrossRefPubMed
8.
go back to reference Yazaki Y, Isobe M, Hiroe M et al (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010CrossRefPubMed Yazaki Y, Isobe M, Hiroe M et al (2001) Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 88:1006–1010CrossRefPubMed
9.
go back to reference Bargout R, Kelly RF (2004) Sarcoid heart disease: clinical course and treatment. Int J Cardiol 97:173–182CrossRefPubMed Bargout R, Kelly RF (2004) Sarcoid heart disease: clinical course and treatment. Int J Cardiol 97:173–182CrossRefPubMed
10.
go back to reference Ise T, Hasegawa T, Morita Y et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100:1165–1172CrossRefPubMed Ise T, Hasegawa T, Morita Y et al (2014) Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100:1165–1172CrossRefPubMed
11.
go back to reference Chapelon-Abric C, de Zuttere D, Duhaut P et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef Chapelon-Abric C, de Zuttere D, Duhaut P et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef
12.
go back to reference Mehta D, Lubitz SA, Frankel Z et al (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435CrossRefPubMed Mehta D, Lubitz SA, Frankel Z et al (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435CrossRefPubMed
14.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 128:30–35CrossRefPubMed Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 128:30–35CrossRefPubMed
15.
go back to reference Judson MA, Baughman RP, Teirstein AS et al (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:75–86PubMed Judson MA, Baughman RP, Teirstein AS et al (1999) Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:75–86PubMed
16.
go back to reference Youssef G, Beanlands RS, Birnie DH et al (2011) Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 97:2078–2087CrossRefPubMed Youssef G, Beanlands RS, Birnie DH et al (2011) Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment. Heart 97:2078–2087CrossRefPubMed
18.
go back to reference Martusewicz-Boros M, Wiatr E, Piotrowska-Kownacka D et al (2007) Cardiac sarcoidosis—own experiences. Pneumonol Alergol Pol 75:100–107PubMed Martusewicz-Boros M, Wiatr E, Piotrowska-Kownacka D et al (2007) Cardiac sarcoidosis—own experiences. Pneumonol Alergol Pol 75:100–107PubMed
19.
go back to reference Martusewicz-Boros M (2006) Cardiac sarcoidosis. Pol Arch Med Wewn 116:1207–1212PubMed Martusewicz-Boros M (2006) Cardiac sarcoidosis. Pol Arch Med Wewn 116:1207–1212PubMed
20.
go back to reference Yeboah J, Lee C, Sharma OP (2011) Cardiac sarcoidosis: a review 2011. Curr Opin Pulm Med 17:308–315CrossRefPubMed Yeboah J, Lee C, Sharma OP (2011) Cardiac sarcoidosis: a review 2011. Curr Opin Pulm Med 17:308–315CrossRefPubMed
21.
go back to reference Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed Iwai K, Sekiguti M, Hosoda Y et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed
22.
go back to reference Nunes H, Freynet O, Naggara N et al (2010) Cardiac sarcoidosis. Semin Respir Crit Care Med 31:428–441CrossRefPubMed Nunes H, Freynet O, Naggara N et al (2010) Cardiac sarcoidosis. Semin Respir Crit Care Med 31:428–441CrossRefPubMed
23.
go back to reference Fahy GJ, Marwick T, McCreery CJ et al (1996) Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109:62–66CrossRefPubMed Fahy GJ, Marwick T, McCreery CJ et al (1996) Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis. Chest 109:62–66CrossRefPubMed
24.
go back to reference Lewin RF, Mor R, Spitzer S et al (1985) Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 110:116–122CrossRefPubMed Lewin RF, Mor R, Spitzer S et al (1985) Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 110:116–122CrossRefPubMed
25.
go back to reference Burstow DJ, Tajik AJ, Bailey KR et al (1989) Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 63:478–482CrossRefPubMed Burstow DJ, Tajik AJ, Bailey KR et al (1989) Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol 63:478–482CrossRefPubMed
26.
go back to reference Uemura A, Morimoto S, Hiramitsu S et al (1999) Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138:299–302CrossRefPubMed Uemura A, Morimoto S, Hiramitsu S et al (1999) Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 138:299–302CrossRefPubMed
28.
go back to reference Osman F, Foundon A, Leyva P et al (2008) Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging. Int J Cardiol 125:e4–e5CrossRefPubMed Osman F, Foundon A, Leyva P et al (2008) Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging. Int J Cardiol 125:e4–e5CrossRefPubMed
29.
go back to reference Manins V, Habersberger J, Pfluger H et al (2009) Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: an Australian single-centre experience. Intern Med J 39:77–82CrossRefPubMed Manins V, Habersberger J, Pfluger H et al (2009) Cardiac magnetic resonance imaging in the evaluation of cardiac sarcoidosis: an Australian single-centre experience. Intern Med J 39:77–82CrossRefPubMed
30.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683–1690CrossRefPubMed Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683–1690CrossRefPubMed
31.
go back to reference Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110–115CrossRefPubMed Tadamura E, Yamamuro M, Kubo S et al (2005) Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. AJR Am J Roentgenol 185:110–115CrossRefPubMed
32.
go back to reference Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323CrossRefPubMed Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323CrossRefPubMed
33.
go back to reference Miyagawa M, Yokoyama R, Nishiyama Y et al (2014) Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J 78:1302–1310CrossRefPubMed Miyagawa M, Yokoyama R, Nishiyama Y et al (2014) Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases. Circ J 78:1302–1310CrossRefPubMed
34.
go back to reference Judson MA, Costabel U, Drent M et al (2014) The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31:19–27PubMed Judson MA, Costabel U, Drent M et al (2014) The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 31:19–27PubMed
35.
go back to reference Nagai T, Kohsaka S, Okuda S et al (2014) Incidence and prognostic significance of myocardial late gadolinium-enhancement in sarcoidosis patients without cardiac manifestation. Chest 146(4):1064–1072CrossRefPubMed Nagai T, Kohsaka S, Okuda S et al (2014) Incidence and prognostic significance of myocardial late gadolinium-enhancement in sarcoidosis patients without cardiac manifestation. Chest 146(4):1064–1072CrossRefPubMed
36.
go back to reference Greulich S, Deluigi CC, Gloekler S et al (2013) CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 6:501–511CrossRefPubMed Greulich S, Deluigi CC, Gloekler S et al (2013) CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 6:501–511CrossRefPubMed
37.
go back to reference Patel AR, Klein MR, Chandra S et al (2011) Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail 13:1231–1237CrossRefPubMed Patel AR, Klein MR, Chandra S et al (2011) Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail 13:1231–1237CrossRefPubMed
38.
go back to reference Cheong BY, Muthupillai R, Nemeth M et al (2009) The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 26:39–46PubMed Cheong BY, Muthupillai R, Nemeth M et al (2009) The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 26:39–46PubMed
39.
go back to reference Yoshida Y, Morimoto S, Hiramitsu S et al (1997) Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 134:382–386CrossRefPubMed Yoshida Y, Morimoto S, Hiramitsu S et al (1997) Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am Heart J 134:382–386CrossRefPubMed
40.
go back to reference Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372–379CrossRefPubMed Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372–379CrossRefPubMed
41.
go back to reference Rybicki BA, Major M, Popovich J Jr et al (1997) Racial differences in sarcoidosis incidence: a 5-years study in a health maintenance organization. Am J Epidemiol 145:234–241CrossRefPubMed Rybicki BA, Major M, Popovich J Jr et al (1997) Racial differences in sarcoidosis incidence: a 5-years study in a health maintenance organization. Am J Epidemiol 145:234–241CrossRefPubMed
Metadata
Title
Cardiac Sarcoidosis: Is it More Common in Men?
Authors
Magdalena M. Martusewicz-Boros
Piotr W. Boros
Elżbieta Wiatr
Anna Kempisty
Dorota Piotrowska-Kownacka
Kazimierz Roszkowski-Śliż
Publication date
01-02-2016
Publisher
Springer US
Published in
Lung / Issue 1/2016
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9805-8

Other articles of this Issue 1/2016

Lung 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.